Skincare company The Skin Diary invited press to its Cell-to-Surface evening at HIDE, Mayfair on July 2.
Guests gathered for a drink’s reception, with the opportunity to network amongst peers, before being seated for a presentation. Kickstarting the evening was Dr Clare Kiely, consultant dermatologist and co-founder of The Skin Diary, who highlighted the need for evidence within the skincare specialty. She urged the need for clinical testing and trials, stating, ‘clinically proven can mean almost anything.’
This was followed by consultant dermatologist, chief scientist and founder of The Skin Diary Professor Chris Griffiths, Officer of the Order of the British Empire (OBE), who discussed what science looks like in practice. Professor Griffiths emphasised the use of fibrillin within skincare, explaining its use as ‘mandatory scaffolding for elastic fibres.’
Lastly, nurse prescriber and strategic and clinic lead for The Skin Diary, Julie Scott, explored the patient perspective, detailing in-clinic protocols. Scott additionally shared video footage of patients expressing their thoughts on the treatment regime, as they highlighted the easy-to-use protocol of the Night Repair Therapy and Age Defence.
Dr Kiely commented, “’Clinically proven’ is used very freely in skincare, yet it can mean anything from an ingredient study in a petri dish to a consumer questionnaire. Our Cell-to-Surface standard is designed to make testing more transparent by assessing the finished formula across three levels. Cellular, to understand its biological effect; clinical, using instrumental testing to measure visible improvement; and surface, reflecting what patients can see and feel in the mirror. We want to raise the bar for evidence and make claims clearer and more meaningful.”